article · European Journal of Pharmacology

Targeting the Keap1-Nrf2 Axis in COPD: Comparative analysis of electrophilic and peptide-based Nrf2 activators in airway and immune cells

Inés Roger
Mònica Aparici
Carlos Puig
Cristina Estornut
Andre M. Davis
Javier Milara
Paula Montero
Fernando Alberício
Alfredo de Diego
Julio Cortijo

2026University of KwaZulu-Natal

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

Genomics, phytochemicals, and oxidative stress
Advanced Glycation End Products research
Chronic Obstructive Pulmonary Disease (COPD) Research

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1016/j.ejphar.2026.178716

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.